These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 2386951)

  • 1. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms.
    Chen CJ; Wang CJ
    Cancer Res; 1990 Sep; 50(17):5470-4. PubMed ID: 2386951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers.
    Chen CJ; Chuang YC; Lin TM; Wu HY
    Cancer Res; 1985 Nov; 45(11 Pt 2):5895-9. PubMed ID: 4053060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer mortality trends in a blackfoot disease endemic community of Taiwan following water source replacement.
    Tsai SM; Wang TN; Ko YC
    J Toxicol Environ Health A; 1998 Nov; 55(6):389-404. PubMed ID: 9833970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder cancer mortality reduction after installation of a tap-water supply system in an arsenious-endemic area in southwestern Taiwan.
    Yang CY; Chiu HF; Chang CC; Ho SC; Wu TN
    Environ Res; 2005 May; 98(1):127-32. PubMed ID: 15721893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung cancer mortality reduction after installation of tap-water supply system in an arseniasis-endemic area in Southwestern Taiwan.
    Chiu HF; Ho SC; Yang CY
    Lung Cancer; 2004 Dec; 46(3):265-70. PubMed ID: 15541810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases.
    Wu MM; Kuo TL; Hwang YH; Chen CJ
    Am J Epidemiol; 1989 Dec; 130(6):1123-32. PubMed ID: 2589305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does arsenic exposure increase the risk for liver cancer?
    Chiu HF; Ho SC; Wang LY; Wu TN; Yang CY
    J Toxicol Environ Health A; 2004 Oct; 67(19):1491-500. PubMed ID: 15371225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does arsenic exposure increase the risk for prostate cancer?
    Yang CY; Chang CC; Chiu HF
    J Toxicol Environ Health A; 2008; 71(23):1559-63. PubMed ID: 18923998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is colon cancer mortality related to arsenic exposure?
    Yang CY; Chang CC; Ho SC; Chiu HF
    J Toxicol Environ Health A; 2008; 71(8):533-8. PubMed ID: 18338288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water.
    Marshall G; Ferreccio C; Yuan Y; Bates MN; Steinmaus C; Selvin S; Liaw J; Smith AH
    J Natl Cancer Inst; 2007 Jun; 99(12):920-8. PubMed ID: 17565158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemic heart disease mortality reduction in an arseniasis-endemic area in southwestern Taiwan after a switch in the tap-water supply system.
    Chang CC; Ho SC; Tsai SS; Yang CY
    J Toxicol Environ Health A; 2004 Sep; 67(17):1353-61. PubMed ID: 15371236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan.
    Chiou HY; Hsueh YM; Liaw KF; Horng SF; Chiang MH; Pu YS; Lin JS; Huang CH; Chen CJ
    Cancer Res; 1995 Mar; 55(6):1296-300. PubMed ID: 7882325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does arsenic exposure increase the risk of development of peripheral vascular diseases in humans?
    Yang CY
    J Toxicol Environ Health A; 2006 Oct; 69(19):1797-804. PubMed ID: 16905509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological characteristics and survival outcome of arsenic related bladder cancer in taiwan.
    Chen CH; Chiou HY; Hsueh YM; Chen CJ; Yu HJ; Pu YS
    J Urol; 2009 Feb; 181(2):547-52; discussion 553. PubMed ID: 19084863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of potential health risk of arsenic-affected groundwater using indicator kriging and dose response model.
    Lee JJ; Jang CS; Wang SW; Liu CW
    Sci Total Environ; 2007 Oct; 384(1-3):151-62. PubMed ID: 17628636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bladder/lung cancer mortality in Blackfoot-disease (BFD)-endemic area villages with low (<150 μg/L) well water arsenic levels--an exploration of the dose-response Poisson analysis.
    Lamm SH; Robbins SA; Zhou C; Lu J; Chen R; Feinleib M
    Regul Toxicol Pharmacol; 2013 Feb; 65(1):147-56. PubMed ID: 23137931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreasing trend in renal disease mortality after cessation from arsenic exposure in a previous arseniasis-endemic area in southwestern Taiwan.
    Chiu HF; Yang CY
    J Toxicol Environ Health A; 2005 Mar; 68(5):319-27. PubMed ID: 15799625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using ecological data to estimate a regression model for individual data: the association between arsenic in drinking water and incidence of skin cancer.
    Guo HR; Lipsitz SR; Hu H; Monson RR
    Environ Res; 1998 Nov; 79(2):82-93. PubMed ID: 9841806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of hepatitis B surface antigen carrier status among residents in the endemic area of chronic arsenicism in Taiwan.
    Lu JN; Chen CJ
    Anticancer Res; 1991; 11(1):229-33. PubMed ID: 2018356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.